Jean-Christophe Marvaud

Dr. Jean-Christophe Marvaud

Team Bactéries Pathogènes et Santé, Micalis Institut, Université Paris-Saclay, Paris, France
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2016 in BMC Genomics
Verified
Journal Article
Open access
PDF file
PDPierre Dehoux
Pierre Dehoux
JMJean-Christophe Marvaud
Jean-Christophe Marvaud
AAAmr Abouelleil
Amr Abouelleil
AEAshlee M. Earl
Ashlee M. Earl
TLThierry Lambert
Thierry Lambert
CDCatherine Dauga
Catherine Dauga
Clostridium bolteae and Clostridium clostridioforme, previously included in the complex C. clostridioforme in the group Clostridium XIVa, remain difficult to distinguish by phenotypic methods. These bacteria, prevailing in the human intestinal microbiota, are opportunistic pathogens with various drug susceptibility patterns. In order to better characterize the two species and to obtain information on their antibiotic resistance genes, we analyzed the genomes of six strains of C. bolteae and six strains of C. clostridioforme, isolated from human infection. The genome length of C. bolteae varied from 6159 to 6398 kb, and 5719 to 6059 CDSs were detected. The genomes of C. clostridioforme were smaller, between 5467 and 5927 kb, and contained 5231 to 5916 CDSs. The two species display different metabolic pathways. The genomes of C. bolteae contained lactose operons involving PTS system and complex regulation, which contribute to phenotypic differentiation from C. clostridioforme. The Acetyl-CoA pathway, similar to that of Faecalibacterium prausnitzii, a major butyrate producer in the human gut, was only found in C. clostridioforme. The two species have also developed diverse flagella mobility systems contributing to gut colonization. Their genomes harboured many CDSs involved in resistance to beta-lactams, glycopeptides, macrolides, chloramphenicol, lincosamides, rifampin, linezolid, bacitracin, aminoglycosides and tetracyclines. Overall antimicrobial resistance genes were similar within a species, but strain-specific resistance genes were found. We discovered a new group of genes coding for rifampin resistance in C. bolteae. C. bolteae 90B3 was resistant to phenicols and linezolide in producing a 23S rRNA methyltransferase. C. clostridioforme 90A8 contained the VanB-type Tn1549 operon conferring vancomycin resistance. We also detected numerous genes encoding proteins related to efflux pump systems. Genomic comparison of C. bolteae and C. clostridiofrome revealed functional differences in butyrate pathways and in flagellar systems, which play a critical role within human microbiota. Most of the resistance genes detected in both species were previously characterized in other bacterial species. A few of them were related to antibiotics inactive against Clostridium spp. Some were part of mobile genetic elements suggesting that these commensals of the human microbiota act as reservoir of antimicrobial resistances.

1 April 2016 in Anaerobe
Verified
Journal Article
Closed access
JBJameel Batah
Jameel Batah
CDCécile Denève-Larrazet
Cécile Denève-Larrazet
PJPierre-Alain Jolivot
Pierre-Alain Jolivot
SKSarah Kuehne
Sarah Kuehne
ACAnne Collignon
Anne Collignon
Imad KansauImad Kansau
Imad Kansau

1 September 2011 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
JMJean-Christophe Marvaud
Jean-Christophe Marvaud
FMFrancine Mory
Francine Mory
TLThierry Lambert
Thierry Lambert
Acquired vancomycin resistance in Gram-positive anaerobes has been reported only in Australia and Canada from rare vanB -positive stool samples in the absence of vancomycin-resistant enterococci (VRE). We report the emergence of VanB-type resistance in Clostridium clostridioforme and Atopobium minutum involved in human infections in France.

Verified
Journal Article
Open access
PDF file
HCHiba Chebly
Hiba Chebly
JMJean-Christophe Marvaud
Jean-Christophe Marvaud
LSLayale Safa
Layale Safa
AEAssem Khalil Elkak
Assem Khalil Elkak
PKPhilippe Hussein Kobeissy
Philippe Hussein Kobeissy
CLCecile Larrazet
Cecile Larrazet
Clostridioides difficile (C. difficile), is a major cause of nosocomial diarrhea and colitis. C. difficile flagellin FliC contributes toxins to gut inflammation by interacting with the immune Toll-like receptor 5 (TLR5) to activate nuclear factor-kappa B (NF-kB) and mitogen-activated protein kinase (MAPK) signaling pathways. Flagella of intracellular pathogens can activate the NLR family CARD domain-containing protein 4 (NLRC4) inflammasome pathway. In this study, we assessed whether flagellin of the extracellular bacterium C. difficile internalizes into epithelial cells and activates the NLRC4 inflammasome. Confocal microscopy showed internalization of recombinant green fluorescent protein (GFP)-FliC into intestinal Caco-2/TC7 cell line. Full-length GFP-FliC activates NLRC4 in Caco-2/TC7 cells in contrast to truncated GFP-FliC lacking the C-terminal region recognized by the inflammasome. FliC induced cleavage of pro-caspase-1 into two subunits, p20 and p10 as well as gasdermin D (GSDMD), suggesting the caspase-1 and NLRC4 inflammasome activation. In addition, colocalization of GFP-FliC and pro-caspase-1 was observed, indicating the FliC-dependent NLRC4 inflammasome activation. Overexpression of the inflammasome-related interleukin (interleukin (IL)-1β, IL-18, and IL-33) encoding genes as well as increasing of the IL-18 synthesis was detected after cell stimulation. Inhibition of I-kappa-B kinase alpha (IKK-α) decreased the FliC-dependent inflammasome interleukin gene expression suggesting a role of the NF-κB pathway in regulating inflammasome. Altogether, these results suggest that FliC internalizes into the Caco-2/TC7 cells and activates the intracellular NLRC4 inflammasome thus contributing to the inflammatory process of C. difficile infection.

1 November 2019 in New Microbes and New Infections
Verified
Journal Article
Open access
JMJean-Christophe Marvaud
Jean-Christophe Marvaud
SQS. Quevedo-Torres
S. Quevedo-Torres
CEC. Eckert
C. Eckert
CJC. Janoir
C. Janoir
FBF. Barbut
F. Barbut
Pathogenesis of Clostridium difficile has been linked to production of toxins, including the large toxins A and B as well as the binary toxin CDT. Until recently, toxin A was only found in combination in clinical strains with the toxin B, unlike toxin B or CDT, which were found alone in toxigenic variants. New toxigenic variants of C. difficile detected in our laboratory from patients with diarrhoea or severe colitis, including a variant producing only toxin A, were tested for virulence in the hamster model, which displays the clinical features of C. difficile disease. Hamsters infected with a strain producing only toxin B induced similar clinical signs, time to death from infection and histologic damage compared to the hypervirulent strain 027. No mortality or clinical signs of infection but caecal histologic damage was found with the variant producing only toxin A. The C. difficile variant strain producing only CDT was able to kill one hamster out of seven; nevertheless, the surviving animals had few alteration of the caecum.

21 February 2020 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
AMAssaf Mizrahi
Assaf Mizrahi
JMJean-Christophe Marvaud
Jean-Christophe Marvaud
BPB. Pilmis
B. Pilmis
JVJ. C. Nguyen Van
J. C. Nguyen Van
CCC. Couzigou
C. Couzigou
TLT. Lambert
T. Lambert
We report a case of a 62-year-old man treated for Streptococcus pneumoniae meningitis by ceftriaxone and dexamethasone. After neurological improvement, neurological degradation by vasculitis occurred, despite effective concentrations of ceftriaxone in the serum and cerebrospinal fluid (CSF). S. pneumoniae with increased MICs to third-generation-cephalosporins (3GC) was isolated from the ventricular fluid 10 days after the isolation of the first strain. Isolate analysis showed that a mutation in the penicillin-binding protein 2X (PBP2X) has occurred under treatment.